USPTO Grants A New Inhaler Patent To Hovione
4/7/2014 10:15:27 AM
LISBON, Portugal, April 7, 2014 /PRNewswire/ -- Hovione announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for a capsule-based, low-cost dry powder inhaler (DPI) to Hovione. This happened less than three years after the patent was filed and after just one Office Action - unusual speed for an inhaler application.
Help employers find you! Check out all the jobs and post your resume.
comments powered by